In a health economy characterized by tepid demand for healthcare services, increasingly disintermediated care delivery and a constrained supply of clinicians, every stakeholder should reexamine their assumptions about mergers and acquisitions (M&A). Contrary to the longstanding assertions of regulators and academics, publicly available data makes clear that certain provider M&A transactions may not negatively impact price and quality or value for money. It is fair to question the provenance of the false narrative that provider consolidation inevitably results in increased price.
Read the full article: Trilliant Health: The Monopolistic Effects of Provider M&A Are Overstated //
Source: https://www.trillianthealth.com/insights/the-compass/the-monopolistic-effects-of-provider-ma-are-overstated